Publication Details

Pubmed9305851
Title: BH3 domain of BAD is required for heterodimerization with BCL-XL and pro-apoptotic activity.
Year: 1997
DOI: https://doi.org/10.1074/jbc.272.39.24101
First Author: Zha
Experimental setup: affinity chromatography technology (Biogrid)
far western blotting (Biogrid)
pull down (Biogrid, MINT)
in vitro (Hprd)
in vivo (Hprd)
two hybrid (Hprd)
coimmunoprecipitation (MINT)
Throughput: Low Throughput (Biogrid)

Interactions

2 interactions
InteractorPartnerSourcesLink
BAD_HUMANB2CL1_HUMANBioGRID, HPRD, MINTdetails
BCL2_HUMANBAD_HUMANBioGRIDdetails